These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33868667)

  • 41. Crohn's Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review.
    Kodali A; Okoye C; Klein D; Mohamoud I; Olanisa OO; Parab P; Chaudhary P; Mukhtar S; Moradi A; Hamid P
    Cureus; 2023 Aug; 15(8):e42995. PubMed ID: 37671212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early life programming of nonalcoholic fatty liver disease in children.
    Soullane S; Willems P; Lee GE; Auger N
    Early Hum Dev; 2022 May; 168():105578. PubMed ID: 35489298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?
    Di N; Zhou X; Chen Y; Zhao X; Li L; Jiang L; Luo B; Chen X; Yang D
    Arch Endocrinol Metab; 2019; 63(2):128-136. PubMed ID: 30916169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.
    Polanco-Briceno S; Glass D; Stuntz M; Caze A
    BMC Res Notes; 2016 Mar; 9():157. PubMed ID: 26969270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men.
    Yang HJ; Shim SG; Ma BO; Kwak JY
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):338-44. PubMed ID: 26636404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.
    Gutiérrez-Grobe Y; Chávez-Tapia N; Sánchez-Valle V; Gavilanes-Espinar JG; Ponciano-Rodríguez G; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2012; 11(3):350-5. PubMed ID: 22481454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.
    Loria P; Adinolfi LE; Bellentani S; Bugianesi E; Grieco A; Fargion S; Gasbarrini A; Loguercio C; Lonardo A; Marchesini G; Marra F; Persico M; Prati D; Baroni GS;
    Dig Liver Dis; 2010 Apr; 42(4):272-82. PubMed ID: 20171943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh.
    Alam S; Noor-E-Alam SM; Chowdhury ZR; Alam M; Kabir J
    World J Hepatol; 2013 May; 5(5):281-7. PubMed ID: 23717739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nutrition mistakes in patients with nonalcoholic fatty liver disease and the ways of correction].
    Nazarenko LI; Petrova IuN; Raĭkhel'son KL; Baranovskiĭ AIu
    Eksp Klin Gastroenterol; 2012; (2):19-24. PubMed ID: 22808787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle.
    Pan Q; Fan JG; Yilmaz Y
    Clin Liver Dis; 2023 May; 27(2):317-332. PubMed ID: 37024210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis.
    Schattenberg JM
    Visc Med; 2020 Oct; 36(5):411-416. PubMed ID: 33251276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonalcoholic Fatty Liver Disease in South Asia.
    Pati GK; Singh SP
    Euroasian J Hepatogastroenterol; 2016; 6(2):154-162. PubMed ID: 29201749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of bariatric surgery on nonalcoholic fatty liver disease.
    de Freitas AC; Campos AC; Coelho JC
    Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):267-74. PubMed ID: 18403923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of endoscopic gastric plication on portosystemic pressure gradient in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease.
    Jirapinyo P; Thompson CC; Garcia-Tsao G; Zucker SD; Ryou M
    Endoscopy; 2024 Jan; 56(1):56-62. PubMed ID: 37532114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
    World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Soejima Y; Fukusato T
    World J Gastroenterol; 2012 May; 18(19):2300-8. PubMed ID: 22654421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy.
    Kopec KL; Burns D
    Nutr Clin Pract; 2011 Oct; 26(5):565-76. PubMed ID: 21947639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease.
    Kandel A; Pant P; Todi S; Kc S; Pandey S
    SAGE Open Med; 2024; 12():20503121241227090. PubMed ID: 38283643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonalcoholic fatty liver disease: diagnosis and management.
    Wilkins T; Tadkod A; Hepburn I; Schade RR
    Am Fam Physician; 2013 Jul; 88(1):35-42. PubMed ID: 23939604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease.
    Lê KA; Bortolotti M
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):477-82. PubMed ID: 18542010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.